Back to trial detailsIntake questionnaire
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Applying to START Mountain Region · West Valley City, Utah
Answer a few short questions to share with the research team.
0 of 3 answered